Absence of EZH2 in leukaemia cells was recently found to aberrantly activate BCAT1, resulting in enhanced mTOR signaling27 and activation of the oncogene Hmga2 by causing an epigenetic switch from H3K27 trimethylation to H3K27 acetylation31. Here, EZH2 is linked to leukemia.